Adeno-associated virus-mediated gene transfer in a rabbit vein graft model

Circulation Journal

Volumn 72, Issue 10, 2008, Pages 1700-1704

  Kilian, Eckehard Gerd ^a   Eifert, Sandra ^a   Beiras Fernandez, Andres ^a   Daebritz, Sabine ^a   Reichenspurner, Hermann ^b   Reichart, Bruno ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF HAMBURG   (Germany)

Author keywords

Adeno associated virus; Beta galactosidase; Transduction; Venous bypass

Indexed keywords

BETA GALACTOSIDASE; PARVOVIRUS VECTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY INTIMA PROLIFERATION; ARTICLE; BYPASS SURGERY; CAROTID ARTERY; CONTROLLED STUDY; CORONARY ARTERY BYPASS SURGERY; EMBRYO; END TO END ANASTOMOSIS; EXPERIMENTAL MODEL; EXPERIMENTAL RABBIT; FEMALE; GENE EXPRESSION; GENE TRANSFER; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; INFLAMMATION; INTERNAL JUGULAR VEIN; NONHUMAN; VEIN GRAFT; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; CELL LINE; DEPENDOVIRUS; FEMALE; GENE TRANSFER TECHNIQUES; GENES, REPORTER; GENETIC VECTORS; GREEN FLUORESCENT PROTEINS; HELA CELLS; HUMANS; JUGULAR VEINS; KIDNEY; PLASMIDS; RABBITS; TRANSPLANTATION, HETEROLOGOUS;

EID: 52949144274     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-07-0921     Document Type: Article

References (17)

1. Grondin CM, Campeau L, Thornton JC, Engle JC, Cross FS, Schreiber H. Coronary artery bypass grafting with saphenous vein. Circulation 1989; 79: I-24-I-29.
2. FitzGibbon GM. RE: JW Butany, TE David, M Ojha. Histological and morphometric analyses of early and late aortocoronary vein grafts and distal anastomoses. Can J Cardiol 1998; 14: 1337,1341-1342.
3. Bulkley BH, Hutchins GM. Accelerated atherosclerosis: A morphologic study of 97 saphenous vein coronary artery bypass grafts. Circulation 1997; 55: 163-169.
4. Petrofski JA, Hata JA, Gehring TR, Hanish SI, Williams ML, Thompson RB, et al. Gene delivery to aortocoronary saphenous vein grafts in a large animal model of inimal hyperplasia. J Thorac Cardiovasc Surg 2004; 127: 27-33.
5. Chu D, Sullivan CC, Weitzman MD, Du L, Wolf PL, Jamieson SW, et al. Direct comparison of efficiency and stability of gene transfer into the mammalian heart using adeno-associated virus versus adenovirus vectors. J Thorac Cardiovasc Surg 2003; 126: 671-679.
6. Eslami MH, Gangadharan SP, Sui X, Rhynhart KK, Snyder RO, Conte MS. Gene delivery to in situ veins: Differential effects of adenovirus and adeno-associated viral vectors. J Vasc Surg 2000; 31: 1149-1159.
7. Monahan PE, Samulski R. Adeno-associated virus vectors for gene therapy: More pros than cons? Molec Med Today 2000; 6: 433-440.
8. Tal J. Adeno-associated virus-based vectors in gene therapy. J Biomed Sci 2000; 7: 279-291.
9. Channon KM, Qian H, Neplioueva V, Blazing MA, Olmez E, Shetty GA, et al. In vivo gene transfer of nitric oxide synthase enhances vasomotor function in carotid arteries from normal and cholesterol-Fed rabbits. Circulation 1998; 3: 1905-1911.
10. Jaffe EA, Nachman RL, Becker CG, Minick CR. Culture of human endothelial cells derived from umbilical veins: Identification by morphologic and immunologic criteria. J Clin Invest 1973; 52: 2745-2756.
11. Xiao X, Li J, Samulski RJ. Production of high-titer recombinant adeno-associated virus vectors in the absence of helper adenovirus. J Virol 1998; 72: 2224-2232.
12. Girod A, Ried M, Wobus C, Lahm H, Leike K, Kleinschmidt J, et al. Genetic capsid modifications allow efficient re-targeting of adenoassociated virus type 2. Nat Med 1999; 5: 1052-1056.
13. Ried MU, Girod A, Leike K, Buning H, Hallek M. Adeno-associated virus capsids displaying immunoglobulin-binding domains permit antibody-mediated vector retargeting to specific cell surface receptors. J Virol 2002; 76: 4559-4566.
14. Zolotukhin S, Byrne BJ, Mason E, Zolotukhin I, Potter M, Chesnut K, et al. Recombinant adeno-associated virus purification using novel methods improves infectious titer and yield. Gene Ther 1999; 6: 973-985.
15. Hacker UT, Gerner FM, Buning H, Hutter M, Reichenspurner H, Stangl M, et al. Standard heparin, low molecular weight heparin, low molecular weight heparinoid, and recombinant hirudin differ in their ability to inhibit transduction by recombinant adeno-associated virus type 2 vectors. Gene Ther 2001; 8: 966-968.
16. Kibbe MR, Tzeng E, Gleixner SL, Watkins SC, Kovesdi I, Lizonova A, et al. Adenovirus-mediated gene transfer of human inducible nitric oxide synthase in porcine vein grafts inhibits intimal hyperplasia. J Vasc Surg 2001; 34: 156-165.
17. Channon KM, Fulton GJ, Gray JL. Efficient adenoviral gene transfer to early venous bypass grafts: Comparison with native vessels. Cardiovasc Res 1997; 35: 505-513.